Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1393365 | European Journal of Medicinal Chemistry | 2008 | 10 Pages |
A series of novel pyrrolidine derivatives were designed, synthesized and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and aminopeptidase N (AP-N). The results showed that these pyrrolidine derivatives exhibited highly selective inhibition against MMP-2 as compared with AP-N. The hydroxamates 8a–c were equally or more potent MMP-2 inhibitors than the positive control LY52. The binding mode of the most potent compound 8a with MMP-2 was proposed. Structure–activity relationships were also briefly discussed.
Graphical abstractA series of novel pyrrolidine derivatives were designed, synthesized and assayed for their inhibitory activities on matrix metalloproteinase 2 (MMP-2) and aminopeptidase N (AP-N). The results showed that these pyrrolidine derivatives exhibited highly selective inhibition against MMP-2 as compared with AP-N. The hydroxamates 8a–c were equally or more potent MMP-2 inhibitors than the positive control LY52. The binding mode of the most potent compound 8a withMMP-2 was proposed. Structure–activity relationships were also briefly discussed.Figure optionsDownload full-size imageDownload as PowerPoint slide